miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer

Marco A. Marra(University of British Columbia), Emilia L. Lim(The Francis Crick Institute), Nina Thiessen(University of Pittsburgh), Gordon L. Robertson, Chad V. Pecot(University of North Carolina at Chapel Hill), Upal Basu-Roy, Amy C. Rowat(California NanoSystems Institute), Yinghong Pan(Guangdong University of Technology), Denise Brooks(University of Copenhagen), Reanne Bowlby(BC Cancer Agency), Lykke Pedersen(Roche (Denmark)), Payal Sipahimalani(Canada's Michael Smith Genome Sciences Centre), Yunfei Wen, Anadulce Hernández-Herrera(University of Houston), Richard A. Moore(Canada's Michael Smith Genome Sciences Centre), Preethi H. Gunaratne(Baylor College of Medicine), Cristian Coarfa(Baylor College of Medicine), Jacquie Schein, Sagar L. Patil(Columbia University), Xinna Zhang(Indiana University Health), Clara Chan, Alka Mansukhani, Jinsong Liu(Guangzhou Institutes of Biomedicine and Health), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Steven J.M. Jones(University of British Columbia), Yussanne Ma, Andrew J. Mungall(Spinal Cord Injury BC), Andy Chu(University of California, Santa Cruz)
UNC Libraries
April 21, 2020
Cited by 3


Related Papers